Viracta Therapeutics Ownership | Who Owns Viracta Therapeutics?

Viracta Therapeutics Ownership Summary

Viracta Therapeutics is owned by 8.94% institutional investors, 2.99% insiders, and 88.08% retail investors. Vanguard group is the largest institutional shareholder, holding 0.73% of VIRX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.30% of its assets in Viracta Therapeutics shares.

VIRX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Viracta Therapeutics	8.94%	2.99%	88.08%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	289.17K	0.73%	$46.56K
Aisling capital management lp	288.57K	0.73%	$46.17K
Renaissance	286.39K	0.72%	$46.08K
Blackrock	273.30K	0.69%	$148.59K
Blackrock funding, inc. /de	234.85K	0.59%	$37.79K
Geode capital management	224.25K	0.57%	$36.09K
Morgan stanley	134.54K	0.34%	$73.15K
Virtu financial	128.23K	0.32%	$21.00K
Ubs group	93.18K	0.24%	$15.00K
Hrt financial lp	82.67K	0.21%	$13.00K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Aisling capital management lp	288.57K	0.02%	$46.17K
Planning capital management	7.27K	0.00%	$3.95K
Virtu financial	128.23K	0.00%	$21.00K
Bridgeway capital management	74.00K	0.00%	$40.23K
Wealthtrust axiom	16.40K	0.00%	$2.64K
Hoylecohen	14.00K	0.00%	$7.61K
Rp management	3.70K	0.00%	$851.00
Two sigma securities	16.49K	0.00%	$2.65K
Trust co of toledo na /oh/	12.32K	0.00%	$1.98K
Xtx topco	14.81K	0.00%	$2.38K

Top Buyers

Holder	Shares	% Assets	Change
Virtu financial	128.23K	0.00%	128.23K
Ubs group	93.18K	-	93.08K
Jane street group	55.42K	-	55.42K
Renaissance	286.39K	0.00%	41.00K
Morgan stanley	134.54K	-	16.53K

Top Sellers

Holder	Shares	% Assets	Change
Bvf inc/il	-	-	-3.61M
Samsara biocapital	-	-	-689.71K
Vanguard group	289.17K	-	-665.31K
Stonepine capital management	-	-	-500.00K
Laurion capital management lp	-	-	-332.19K

New Positions

Holder	Shares	% Assets	Change	Value
Jane street group	55.42K	-	55.42K	$8.92K
Two sigma securities	16.49K	0.00%	16.49K	$2.65K
Baader bank aktiengesellschaft	10.83K	0.00%	10.83K	$1.56K

Sold Out

Holder	Change
Qube research	-2.00
Parallel advisors	-8.00
Newedge advisors	-14.00
Jones financial companies lllp	-1.00K
Nbc securities	-1.40K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	31	-16.22%	3,536,196	-36.71%	8	4.48%	11	-31.25%	4	-33.33%
Sep 30, 2024	37	-9.76%	5,587,200	-38.10%	14	2.68%	16	60.00%	6	-25.00%
Jun 30, 2024	41	-	9,025,612	-3.92%	22	3.88%	10	-23.08%	8	33.33%
Mar 31, 2024	41	-6.82%	9,393,496	-3.67%	24	3.83%	13	-13.33%	6	-14.29%
Dec 31, 2023	44	2.33%	9,751,265	0.61%	25	3.99%	15	-6.25%	7	-12.50%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	513.47K	1.30%	-131.32K
Vanguard Institutional Extnd Mkt Idx Tr	282.49K	0.71%	-
Fidelity Extended Market Index	140.03K	0.35%	-1.13K
Bridgeway Ultra-Small Company Market	74.00K	0.19%	-
BlackRock Extended Equity Market K	49.16K	0.12%	-21.00
Extended Equity Market Fund K	48.49K	0.12%	-668.00
Fidelity Total Market Index	41.22K	0.10%	-
Fidelity Series Total Market Index	28.47K	0.07%	-
Vanguard Instl Ttl Stck Mkt Idx Tr	20.52K	0.05%	-7.93K
Fidelity Nasdaq Composite Index	19.26K	0.05%	-6.50K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Feb 27, 2024	Chevallard Daniel R.	CFO and COO	Sell	$2.49K
Nov 30, 2023	Rothera Mark	President and CEO	Buy	$25.73K
Dec 01, 2023	Rothera Mark	President and CEO	Buy	$23.63K
Nov 28, 2023	Chevallard Daniel R.	CFO and COO	Sell	$1.86K
Aug 28, 2023	Chevallard Daniel R.	CFO and COO	Sell	$5.09K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	-
2024 Q3	-	-
2024 Q2	-	-
2024 Q1	-	1
2023 Q4	2	1

VIRX Ownership FAQ

Who Owns Viracta Therapeutics?

Viracta Therapeutics shareholders are primarily institutional investors at 8.94%, followed by 2.99% insiders and 88.07% retail investors. The average institutional ownership in Viracta Therapeutics's industry, Biotech Stocks , is 68.48%, which Viracta Therapeutics falls below.

Who owns the most shares of Viracta Therapeutics?

Viracta Therapeutics’s largest shareholders are Vanguard group (289.17K shares, 0.73%), Aisling capital management lp (288.57K shares, 0.73%), and Renaissance (286.4K shares, 0.72%). Together, they hold 2.18% of Viracta Therapeutics’s total shares outstanding.

Does Blackrock own Viracta Therapeutics?

Yes, BlackRock owns 0.69% of Viracta Therapeutics, totaling 273.3K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 148.59K$. In the last quarter, BlackRock decreased its holdings by -30.683K shares, a -10.09% change.

Who is Viracta Therapeutics’s biggest shareholder by percentage of total assets invested?

Aisling capital management lp is Viracta Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.02% of its assets in 288.57K Viracta Therapeutics shares, valued at 46.17K$.

Who is the top mutual fund holder of Viracta Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Viracta Therapeutics shares, with 1.30% of its total shares outstanding invested in 513.47K Viracta Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools